The PI3K-AKT-mTOR pathway, which has been shown to be upregulated in endocrine-resistant breast cancer cells53, may act as a compensatory pro-proliferation pathway following SERPINA3 inhibition. This evidence concerns the gene MTOR and breast cancer.